+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Hemostasis Diagnostics Market by Product (Instruments And Analyzers, Reagents And Kits, Software And Services), Technology (Chromogenic Assay, Clotting Assay, Immunologic Assay), End User, Application - Global Forecast 2025-2030- Product Image
Hemostasis Diagnostics Market by Product (Instruments And Analyzers, Reagents And Kits, Software And Services), Technology (Chromogenic Assay, Clotting Assay, Immunologic Assay), End User, Application - Global Forecast 2025-2030- Product Image
Sale

Hemostasis Diagnostics Market by Product (Instruments And Analyzers, Reagents And Kits, Software And Services), Technology (Chromogenic Assay, Clotting Assay, Immunologic Assay), End User, Application - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 192 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5887515
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The hemostasis diagnostics market is rapidly evolving, fueled by advances in clinical testing technology, a strong shift toward decentralized diagnostics, and growing demand for precise coagulation management across care environments. Senior decision-makers need reliable, actionable insights to navigate this complex and high-stakes industry.

Market Snapshot: Hemostasis Diagnostics Market Size and Growth

The global hemostasis diagnostics market is experiencing sustained expansion, with a current value of USD 620.10 million in 2024 and projected to reach USD 672.05 million by 2025. Expected to grow at a CAGR of 8.22%, the market is anticipated to achieve USD 996.60 million by 2030. This growth reflects rising demand for advanced diagnostic solutions, increased prevalence of cardiovascular and bleeding disorders, and the rapid deployment of innovative technologies across core laboratories and point-of-care settings.

Scope & Segmentation of the Hemostasis Diagnostics Market

  • Products: Instruments and analyzers support high-throughput laboratory operations, including automated analyzers and point of care instruments. Reagents and kits include consumables and ready-to-use kits, crucial for standardizing critical assays. Software and services encompass laboratory information systems and a range of support services such as calibration, preventive maintenance, and training.
  • Technologies: Key assay modalities include chromogenic assays (Factor VIII, Factor X, thrombin inhibition), clotting assays (activated partial thromboplastin time, fibrinogen, prothrombin, thrombin time), immunologic assays (antiphospholipid antibodies, D-dimer, Protein C/S), and molecular assays (genotyping, PCR-based tests).
  • End Users: Diagnostic laboratories—both hospital-based and independent—are primary adopters, alongside hospitals, clinics at secondary and tertiary levels, and academic research institutes specializing in assay development and clinical workflow integration.
  • Applications: Disease diagnosis includes bleeding disorders, disseminated intravascular coagulation, and thrombophilia. Screening and prevention cover population and prenatal initiatives. Treatment monitoring addresses anticoagulant therapy, including DOAC, heparin, and warfarin protocols.
  • Regions: Americas, Europe, Middle East, Africa, and Asia Pacific drive adoption trends, with significant variation in regulatory context, healthcare investment, and infrastructure maturity.
  • Key Players: Market innovators and leaders include Siemens Healthineers AG, F. Hoffmann-La Roche AG, Danaher Corporation, Abbott Laboratories, Sysmex Corporation, Instrumentation Laboratory Company, Thermo Fisher Scientific Inc., Diagnostica Stago SAS, Ortho Clinical Diagnostics Holdings, LLC, and bioMérieux SA.

Key Takeaways for Senior Decision-Makers

  • Advancements in instrument automation and reagent standardization are enabling laboratories to deliver critical analytical accuracy and faster turnaround times, directly influencing clinical outcomes.
  • The integration of artificial intelligence and laboratory information systems is transforming traditional laboratory workflows, facilitating data-driven decision-making in patient care and resource allocation.
  • Expanding point-of-care testing is decentralizing diagnostics beyond central labs, equipping care teams with near-patient results for time-sensitive clinical decisions in emergency and outpatient settings.
  • Molecular and immunologic assays are supporting the evolution of personalized medicine, allowing clinicians to tailor anticoagulant therapies based on individual genetic and biomarker profiles.
  • Market participants adopting robust supply chain management and regional manufacturing partnerships are better positioned to respond to evolving regulatory landscapes and mitigate operational risks.
  • Collaboration between diagnostics manufacturers, software developers, and healthcare providers is essential to integrate innovative solutions that span from laboratory to bedside, enhancing patient care pathways.

Impact of 2025 US Tariffs on Hemostasis Diagnostics

New US tariffs scheduled for 2025 are poised to disrupt hemostasis diagnostics supply chains, potentially increasing procurement costs for manufacturers relying on imports of reagents and specialized instruments. In response, industry stakeholders are emphasizing regional manufacturing partnerships and smarter vendor diversification strategies to limit exposure to shifting trade policies. Proactive adoption of integrated supply chain platforms will help maintain inventory stability and protect margins while sustaining high standards of patient care.

Methodology & Data Sources

This market analysis uses a dual approach, combining secondary research from peer-reviewed publications, regulatory filings, and patent databases with primary research through direct interviews and industry surveys. Findings are cross-verified using data triangulation and multi-stakeholder expert validation, ensuring accuracy, credibility, and compliance with ethical standards.

Why This Report Matters

  • Enables strategic planning using up-to-date segmentation insights and competitive analysis tailored for growth-oriented organizations in the hemostasis diagnostics sector.
  • Empowers leaders to identify new partnership and innovation opportunities across technologies, applications, and geographies.
  • Supports robust risk management and procurement decisions, accounting for evolving regulatory requirements and supply chain disruptions.

Conclusion

Senior leaders in the hemostasis diagnostics industry will be best equipped by leveraging actionable market intelligence, technological advances, and collaborative strategies. This report provides a clear path to navigate change and sustain growth while upholding the highest standards of clinical and operational excellence.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expansion of point-of-care coagulation testing solutions driven by rising demand in remote settings
5.2. Advancements in microfluidic technology enabling rapid hemostasis profiling at the bedside
5.3. Integration of artificial intelligence algorithms for predictive bleeding risk assessment in surgery
5.4. Surge in adoption of novel direct oral anticoagulants requiring specialized monitoring assays
5.5. Growth of multiplex hemostasis panels combining coagulation, platelet function, and fibrinolysis tests
5.6. Increasing collaborations between diagnostic manufacturers and academic centers for assay development
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Hemostasis Diagnostics Market, by Product
8.1. Introduction
8.2. Instruments And Analyzers
8.2.1. Automated Analyzers
8.2.2. Point Of Care Instruments
8.3. Reagents And Kits
8.3.1. Consumables
8.3.2. Ready To Use Kits
8.4. Software And Services
8.4.1. Laboratory Information Systems
8.4.2. Maintenance And Support Services
8.4.2.1. Calibration
8.4.2.2. Preventive Maintenance
8.4.2.3. Training
9. Hemostasis Diagnostics Market, by Technology
9.1. Introduction
9.2. Chromogenic Assay
9.2.1. Factor VIII Assay
9.2.2. Factor X Assay
9.2.3. Thrombin Inhibition Assay
9.3. Clotting Assay
9.3.1. Activated Partial Thromboplastin Time
9.3.2. Fibrinogen Assay
9.3.3. Prothrombin Time
9.3.4. Thrombin Time
9.4. Immunologic Assay
9.4.1. Antiphospholipid Antibodies
9.4.2. D Dimer
9.4.3. Protein C S
9.5. Molecular Assay
9.5.1. Genotyping Tests
9.5.2. Pcr Based Tests
10. Hemostasis Diagnostics Market, by End User
10.1. Introduction
10.2. Diagnostic Laboratories
10.2.1. Hospital Based Labs
10.2.2. Independent Labs
10.3. Hospitals And Clinics
10.3.1. Secondary Care Hospitals
10.3.2. Tertiary Care Hospitals
10.4. Research Institutes
10.4.1. Academic Research
11. Hemostasis Diagnostics Market, by Application
11.1. Introduction
11.2. Disease Diagnosis
11.2.1. Bleeding Disorders
11.2.2. D I C
11.2.3. Thrombophilia
11.3. Screening And Prevention
11.3.1. Population Screening
11.3.2. Prenatal Screening
11.4. Treatment Monitoring
11.4.1. Anticoagulant Therapy Monitoring
11.4.2. Doac
11.4.3. Heparin
11.4.4. Warfarin
12. Americas Hemostasis Diagnostics Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Hemostasis Diagnostics Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Hemostasis Diagnostics Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Siemens Healthineers AG
15.3.2. F. Hoffmann-La Roche AG
15.3.3. Danaher Corporation
15.3.4. Abbott Laboratories
15.3.5. Sysmex Corporation
15.3.6. Instrumentation Laboratory Company
15.3.7. Thermo Fisher Scientific Inc.
15.3.8. Diagnostica Stago SAS
15.3.9. Ortho Clinical Diagnostics Holdings, LLC
15.3.10. bioMérieux SA
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. HEMOSTASIS DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 6. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. HEMOSTASIS DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. HEMOSTASIS DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. HEMOSTASIS DIAGNOSTICS MARKET: RESEARCHAI
FIGURE 24. HEMOSTASIS DIAGNOSTICS MARKET: RESEARCHSTATISTICS
FIGURE 25. HEMOSTASIS DIAGNOSTICS MARKET: RESEARCHCONTACTS
FIGURE 26. HEMOSTASIS DIAGNOSTICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. HEMOSTASIS DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND ANALYZERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY AUTOMATED ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY AUTOMATED ANALYZERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY POINT OF CARE INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY POINT OF CARE INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND ANALYZERS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND ANALYZERS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY REAGENTS AND KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY REAGENTS AND KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY READY TO USE KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY READY TO USE KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY REAGENTS AND KITS, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY REAGENTS AND KITS, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY LABORATORY INFORMATION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY LABORATORY INFORMATION SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MAINTENANCE AND SUPPORT SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MAINTENANCE AND SUPPORT SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CALIBRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CALIBRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PREVENTIVE MAINTENANCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PREVENTIVE MAINTENANCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TRAINING, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TRAINING, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MAINTENANCE AND SUPPORT SERVICES, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MAINTENANCE AND SUPPORT SERVICES, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CHROMOGENIC ASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CHROMOGENIC ASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY FACTOR VIII ASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY FACTOR VIII ASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY FACTOR X ASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY FACTOR X ASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY THROMBIN INHIBITION ASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY THROMBIN INHIBITION ASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CHROMOGENIC ASSAY, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CHROMOGENIC ASSAY, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CLOTTING ASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CLOTTING ASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY ACTIVATED PARTIAL THROMBOPLASTIN TIME, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY ACTIVATED PARTIAL THROMBOPLASTIN TIME, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY FIBRINOGEN ASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY FIBRINOGEN ASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PROTHROMBIN TIME, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PROTHROMBIN TIME, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY THROMBIN TIME, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY THROMBIN TIME, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CLOTTING ASSAY, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CLOTTING ASSAY, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGIC ASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGIC ASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY ANTIPHOSPHOLIPID ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY ANTIPHOSPHOLIPID ANTIBODIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY D DIMER, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY D DIMER, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PROTEIN C S, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PROTEIN C S, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGIC ASSAY, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGIC ASSAY, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR ASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR ASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY GENOTYPING TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY GENOTYPING TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PCR BASED TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PCR BASED TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR ASSAY, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR ASSAY, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY HOSPITAL BASED LABS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY HOSPITAL BASED LABS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY INDEPENDENT LABS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY INDEPENDENT LABS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SECONDARY CARE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SECONDARY CARE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY BLEEDING DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY BLEEDING DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY D I C, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY D I C, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY THROMBOPHILIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY THROMBOPHILIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SCREENING AND PREVENTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SCREENING AND PREVENTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY POPULATION SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY POPULATION SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRENATAL SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRENATAL SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SCREENING AND PREVENTION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SCREENING AND PREVENTION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TREATMENT MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TREATMENT MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY ANTICOAGULANT THERAPY MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY ANTICOAGULANT THERAPY MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DOAC, BY REGION, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DOAC, BY REGION, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY HEPARIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY HEPARIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY WARFARIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY WARFARIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TREATMENT MONITORING, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TREATMENT MONITORING, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND ANALYZERS, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND ANALYZERS, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY REAGENTS AND KITS, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY REAGENTS AND KITS, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MAINTENANCE AND SUPPORT SERVICES, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MAINTENANCE AND SUPPORT SERVICES, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CHROMOGENIC ASSAY, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CHROMOGENIC ASSAY, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CLOTTING ASSAY, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CLOTTING ASSAY, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGIC ASSAY, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGIC ASSAY, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR ASSAY, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR ASSAY, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2025-2030 (USD MILLION)
TABLE 167. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 168. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 169. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 170. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 171. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 172. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 173. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SCREENING AND PREVENTION, 2018-2024 (USD MILLION)
TABLE 174. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SCREENING AND PREVENTION, 2025-2030 (USD MILLION)
TABLE 175. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TREATMENT MONITORING, 2018-2024 (USD MILLION)
TABLE 176. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TREATMENT MONITORING, 2025-2030 (USD MILLION)
TABLE 177. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 178. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND ANALYZERS, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND ANALYZERS, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY REAGENTS AND KITS, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY REAGENTS AND KITS, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MAINTENANCE AND SUPPORT SERVICES, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MAINTENANCE AND SUPPORT SERVICES, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CHROMOGENIC ASSAY, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CHROMOGENIC ASSAY, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CLOTTING ASSAY, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CLOTTING ASSAY, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGIC ASSAY, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGIC ASSAY, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR ASSAY, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR ASSAY, 2025-2030 (USD MILLION)
TABLE 199. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 202. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 203. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2024 (USD MILLION)
TABLE 204. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2025-2030 (USD MILLION)
TABLE 205. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 206. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 207. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 208. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 209. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 210. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 211. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SCREENING AND PREVENTION, 2018-2024 (USD MILLION)
TABLE 212. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SCREENING AND PREVENTION, 2025-2030 (USD MILLION)
TABLE 213. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TREATMENT MONITORING, 2018-2024 (USD MILLION)
TABLE 214. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TREATMENT MONITORING, 2025-2030 (USD MILLION)
TABLE 215. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 216. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 217. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 218. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 219. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND ANALYZERS, 2018-2024 (USD MILLION)
TABLE 220. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND ANALYZERS, 2025-2030 (USD MILLION)
TABLE 221. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY REAGENTS AND KITS, 2018-2024 (USD MILLION)
TABLE 222. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY REAGENTS AND KITS, 2025-2030 (USD MILLION)
TABLE 223. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 224. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 225. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MAINTENANCE AND SUPPORT SERVICES, 2018-2024 (USD MILLION)
TABLE 226. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MAINTENANCE AND SUPPORT SERVICES, 2025-2030 (USD MILLION)
TABLE 227. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 228. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 229. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CHROMOGENIC ASSAY, 2018-2024 (USD MILLION)
TABLE 230. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CHROMOGENIC ASSAY, 2025-2030 (USD MILLION)
TABLE 231. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CLOTTING ASSAY, 2018-2024 (USD MILLION)
TABLE 232. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CLOTTING ASSAY, 2025-2030 (USD MILLION)
TABLE 233. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGIC ASSAY, 2018-2024 (USD MILLION)
TABLE 234. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGIC ASSAY, 2025-2030 (USD MILLION)
TABLE 235. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR ASSAY, 2018-2024 (USD MILLION)
TABLE 236. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR ASSAY, 2025-2030 (USD MILLION)
TABLE 237. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 240. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 241. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2024 (USD MILLION)
TABLE 242. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2025-2030 (USD MILLION)
TABLE 243. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 244. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 245. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 246. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 247. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 248. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 249. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SCREENING AND PREVENTION, 2018-2024 (USD MILLION)
TABLE 250. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SCREENING AND PREVENTION, 2025-2030 (USD MILLION)
TABLE 251. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TREATMENT MONITORING, 2018-2024 (USD MILLION)
TABLE 252. CANADA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TREATMENT MONITORING, 2025-2030 (USD MILLION)
TABLE 253. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 254. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 255. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND ANALYZERS, 2018-2024 (USD MILLION)
TABLE 256. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND ANALYZERS, 2025-2030 (USD MILLION)
TABLE 257. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY REAGENTS AND KITS, 2018-2024 (USD MILLION)
TABLE 258. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY REAGENTS AND KITS, 2025-2030 (USD MILLION)
TABLE 259. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 260. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 261. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MAINTENANCE AND SUPPORT SERVICES, 2018-2024 (USD MILLION)
TABLE 262. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MAINTENANCE AND SUPPORT SERVICES, 2025-2030 (USD MILLION)
TABLE 263. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 264. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 265. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CHROMOGENIC ASSAY, 2018-2024 (USD MILLION)
TABLE 266. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CHROMOGENIC ASSAY, 2025-2030 (USD MILLION)
TABLE 267. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CLOTTING ASSAY, 2018-2024 (USD MILLION)
TABLE 268. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CLOTTING ASSAY, 2025-2030 (USD MILLION)
TABLE 269. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGIC ASSAY, 2018-2024 (USD MILLION)
TABLE 270. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGIC ASSAY, 2025-2030 (USD MILLION)
TABLE 271. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR ASSAY, 2018-2024 (USD MILLION)
TABLE 272. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR ASSAY, 2025-2030 (USD MILLION)
TABLE 273. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 276. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 277. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2024 (USD MILLION)
TABLE 278. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2025-2030 (USD MILLION)
TABLE 279. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 280. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 281. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 282. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 283. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 284. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 285. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SCREENING AND PREVENTION, 2018-2024 (USD MILLION)
TABLE 286. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SCREENING AND PREVENTION, 2025-2030 (USD MILLION)
TABLE 287. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TREATMENT MONITORING, 2018-2024 (USD MILLION)
TABLE 288. MEXICO HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TREATMENT MONITORING, 2025-2030 (USD MILLION)
TABLE 289. BRAZIL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 290. BRAZIL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 291. BRAZIL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND ANALYZERS, 2018-2024 (USD MILLION)
TABLE 292. BRAZIL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND ANALYZERS, 2025-2030 (USD MILLION)
TABLE 293. BRAZIL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY REAGENTS AND KITS, 2018-2024 (USD MILLION)
TABLE 294. BRAZIL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY REAGENTS AND KITS, 2025-2030 (USD MILLION)
TABLE 295. BRAZIL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2024 (USD MILLION)
TABLE 296. BRAZIL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2025-2030 (USD MILLION)
TABLE 297. BRAZIL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MAINTENANCE AND SUPPORT SERVICES, 2018-2024 (USD MILLION)
TABLE 298. BRAZIL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MAINTENANCE AND SUPPORT SERVICES, 2025-2030 (USD MILLION)
TABLE 299. BRAZIL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 300. BRAZIL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 301. BRAZIL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CHROMOGENIC ASSAY, 2018-2024 (USD MILLION)
TABLE 302. BRAZIL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CHROMOGENIC ASSAY, 2025-2030 (USD MILLION)
TABLE 303. BRAZIL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CLOTTING ASSAY, 2018-2024 (USD MILLION)
TABLE 304. BRAZIL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CLOTTING ASSAY, 2025-2030 (USD MILLION)
TABLE 305. BRAZIL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGIC ASSAY, 2018-2024 (USD MILLION)
TABLE 306. BRAZIL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGIC ASSAY, 2025-2030 (USD MILLION)
TABLE 307. BRAZIL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR ASSAY, 2018-2024 (USD MILLION)
TABLE 308. BRAZIL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR ASSAY, 2025-2030 (USD MILLION)
TABLE 309. BRAZIL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 310. BRAZIL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 311. BRAZIL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 312. BRAZIL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 313. BRAZIL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2024 (USD MILLION)
TABLE 314. BRAZIL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2025-2030 (USD MILLION)
TABLE 315. BRAZIL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Hemostasis Diagnostics market report include:
  • Siemens Healthineers AG
  • F. Hoffmann-La Roche AG
  • Danaher Corporation
  • Abbott Laboratories
  • Sysmex Corporation
  • Instrumentation Laboratory Company
  • Thermo Fisher Scientific Inc.
  • Diagnostica Stago SAS
  • Ortho Clinical Diagnostics Holdings, LLC
  • bioMérieux SA

Table Information

Report AttributeDetails
No. of Pages192
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 672.05 Million
Forecasted Market Value ( USD ) by 2030 $ 996.6 Million
Compound Annual Growth Rate8.2%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Coagulation & Hemostasis Testing Market by End User (Diagnostic Labs, Hospital Labs, Physician Offices), Technology (Electrochemical Detection, Immunoassays, Microfluidics), Workflow, Products, Test Type - Global Forecast 2025-2030 - Product Image

Coagulation & Hemostasis Testing Market by End User (Diagnostic Labs, Hospital Labs, Physician Offices), Technology (Electrochemical Detection, Immunoassays, Microfluidics), Workflow, Products, Test Type - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Hemostasis Diagnostics Market Size, Share & Trends Analysis Report By Product (POC Testing Systems, Consumables), By Test (Prothrombin Time Test, D Dimer Test), By End Use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Hemostasis Diagnostics Market Size, Share & Trends Analysis Report By Product (POC Testing Systems, Consumables), By Test (Prothrombin Time Test, D Dimer Test), By End Use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 180 Pages
  • Global
From
Hemostasis Diagnostics - Global Strategic Business Report - Product Image

Hemostasis Diagnostics - Global Strategic Business Report

  • Report
  • 173 Pages
  • Global
From
Hemostasis Diagnostic Devices and Equipment Market Report 2025 - Product Image

Hemostasis Diagnostic Devices and Equipment Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Hemostasis Market Report and Forecast 2025-2034 - Product Image

Hemostasis Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From

About the Hemostasis Test Market

The Hemostasis Test market is a subset of the larger Coagulation and Hemostasis Testing market. Hemostasis Tests are used to measure the ability of the body to form clots and stop bleeding. These tests are used to diagnose and monitor a variety of conditions, including bleeding disorders, thrombosis, and other clotting-related diseases. Hemostasis Tests are typically performed in a laboratory setting, using a variety of methods, including manual and automated techniques. The Hemostasis Test market is highly competitive, with a number of companies offering a range of products and services. These include Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, Sysmex Corporation, and Beckman Coulter. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.